biostudies-literatureCurrier JSNational Institute of Allergy and Infectious DiseasesNIAID NIH HHSNational Institutes of HealthNIH HHSS77-S82https://www.ebi.ac.uk/biostudies/studies/S-EPMC10469341biostudies-literatureUnknown228(Suppl 2)Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.The Journal of infectious diseasesACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.PMC10469341UM1 AI069423UM1 AI106701U01 AI068636UM1 AI069424UM1 AI068634UM1AI068636UM1AI068634UM1AI106701U01 AI069424UM1 AI069463UM1 AI069432Waring LHosey LScience FErhardt BACTIV-2/A5401 Study TeamChew KWMoser CSmith DMJavan ACEron JJWohl DAPatel NAdams SCurrier JSDaar ESRoa JHessinger DHughes MDfalseACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.2023-01-01T00:00:00Z2023 Aug2026-04-07T14:54:16.964Z2024-10-16T14:39:00.754ZS-EPMC104693413765023110.1093/infdis/jiad246